The Effect of Biochemical Remission on Bone Metabolism in Cushing's Syndrome: A 2‐Year Follow‐Up Study-Reference-Cited by-同舟云学术

The Effect of Biochemical Remission on Bone Metabolism in Cushing's Syndrome: A 2‐Year Follow‐Up Study

Published:2020-05-08 Issue:9 Volume:35 Page:1711-1717
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Braun Leah T¹^ORCID,Fazel Julia¹,Zopp Stephanie¹,Benedix Sarina¹,Osswald‐Kopp Andrea¹,Riester Anna¹,Rubinstein German¹,Seidensticker Max²,Beuschlein Felix¹³,Drey Michael¹,Bidlingmaier Martin¹,Schmidmaier Ralf¹,Reincke Martin¹

Affiliation:

1. Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig‐Maximilians‐Universität München Munich Germany

2. Klinik und Poliklinik für Radiologie Klinikum der Universität, Ludwig‐Maximilians‐Universität München Munich Germany

3. Klinik für Endokrinologie, Diabetologie und Klinische Ernährung Universitätsspital Zürich Zürich Switzerland

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4033

Reference27 articles.

1. Cushing's syndrome

2. Glucocorticoid-induced osteoporosis: lessons from Cushing's syndrome

3. Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing's syndrome

4. Screening for Cushing’s syndrome: Is it worthwhile?

5. Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cushing’s disease and bone;Pituitary;2024-07-15

2. The efficacy of bisphosphonates for osteoporosis in young Cushing’s disease patients with biochemical remission: a retrospective cohort study;Frontiers in Endocrinology;2024-06-21

3. Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease;Journal of Endocrinological Investigation;2024-05-02

4. Blocking CCN2 Reduces Established Bone Loss Induced by Prolonged Intense Loading by Increasing Osteoblast Activity in Rats;JBMR Plus;2023-06-16

5. Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome;European Journal of Endocrinology;2023-03-27